Over 30 years of research experience in National Centers (Complutense University of Madrid & Institute Cajal –CSIC-) as well as International Centers in Switzerland (Novartis Pharma), France (INSERM), USA (Cornell Medical College & Florida Atlantic University), United Kingdom (The open University & The University of Manchester and Czeck Republic (Institute of Experimental Medicine). Nowadays and from 2009, I work for IKERBASQUE (Basque Foundation for Science, Spain).
Illana Gozes
Tel Aviv University
Israel
Professor Emerita Illana Gozes, formerly, The Lily and Avraham Gildor Chair for the Investigation of Growth Factors, currently, Head, Dr. Diana and Zelman Elton (Elbaum) Laboratory for Molecular Neuroendocrinology, Department of Human Molecular Genetics and Biochemistry, Faculty of Medical and Health Sciences, Adams Super Center for Brain Studies and Sagol School of Neuroscience, Tel Aviv University, President, European Society for Neurochemistry, Editor-in-Chief, Journal of Molecular Neuroscience, Vice President Drug Development ExoNavis Therapeutics Ltd. B.Sc., Tel Aviv University, Ph.D. Weizmann Institute of Science, Postdoctoral fellowships, MIT and Salk Institute (USA), Sabbaticals, NIH (Fogarty-Scholar-in-Residence) and Humboldt Research Award (Germany). Multiple prizes, papers and patents.
Paul Chazot
Durham University
UK
Professor Chazot’s research group focuses on the identification, characterisation and validation of novel drug targets for the treatment of the major chronic CNS pathologies. Professor Chazot has developed a range of new clinical development programmes over the last 20 years, one for chronic pain (Votucalis), one for post-concussion syndrome, and one for Alzheimer’s Disease (PBM-T 1068nm), the former at the pipeline stage, and the latter two at the Phase 2 clinical stage in the US, and soon to be UK. He is an academic partner for the spin-out company Nevrargenics, (http://nevrargenics.com). Ellorarxine has MHRA approval for ALS/FTD, recruiting in 2025.
Marie J. Hayes
University of Maine
USA
Professor Marie Hayes, Ph.D., is active Emeritus professor from the University of Maine, the department of Psychology and the Program of Biomedical Science and Engineering. Dr. Hayes has worked as a biomedical scientist studying sleep deprivation in relation to microarousals, sleep movements and respiratory function in diseases of development and aging. Her collaborative research program on sleep and neurological disease has led to development of a novel sleep mattress for noninvasive recordings in aging individuals at risk for Alzheimer’s disease. Recent NIH work has focused on respiratory-movement coupling during sleep as a biobehavioral marker of early Alzheimer’s disease using machine learning to identify MCI risk in older adults from the community
